The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment

Retina

Volumn 20, Issue 1, 2000, Pages 69-75

  Unal, Melih ^a   Peyman, Gholam A ^a  

^a LSU EYE CENTER   (United States)

Author keywords

Plasminogen; Posteroir vitrous detachment; Rabbit; Urokinase

Indexed keywords

PLASMINOGEN; UROKINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFICACY; NONHUMAN; RABBIT; VITREOUS BODY DETACHMENT;

EID: 0034129529     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200001000-00013     Document Type: Article

References (42)

1. Davis MD. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 1965;74:741-751.
2. Tolentino FI, Lee PF, Schepens CL. Biomicroscopic study of vitreous cavity in diabetic retinopathy. Arch Ophthalmol 1966; 75:238-246.
3. Takahashi M, Trempe CL, Maguire K, McMeel JW. Vitreoretinal relationship in diabetic retinopathy: a biomicroscopic evaluation. Arch Ophthalmol 1981;99:241-245.
4. Tagawa H, McMeel JW, Trempe CL. Role of the vitreous in diabetic retinopathy: II. Active and inactive vitreous changes. Ophthalmology 1986;93:1188-1192.
5. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology 1990;97:889-891.
6. Smiddy WE, Michels RG, Glaser BM, deBustros S. Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol 1988;106:624-628.
7. Chan CK, Wessels IF, Friedrichsen EJ. Treatment of idiopathic macular holes by induced posterior vitreous detachment. Ophthalmology 1995;102:757-767.
8. da Cruz L, Constable IJ, Barry CJ. Spontaneous resolution of a full-thickness macular hole with good visual acuity. Arch Ophthalmol 1997;115:130-131.
9. Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988;106:629-639.
10. Johnson RN, Gass JD. Idiopathic macular holes. Observations, stages of formation, and implications for surgical intervention. Ophthalmology 1988;95:917-924.
11. Gordon LW, Glaser BM, Ie D, et al. Full-thickness macular hole formation in eyes with a pre-existing complete posterior vitreous detachment. Ophthalmology 1995;102:1702-1705.
12. Avunduk AM, Cetinkaya K, Kapicioglu Z, Kaya C. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol 1997;75:441-442.
13. Hendrikse F, Yeo KT. Role of the vitreous body in diabetic retinopathy. Klin Monatsbl Augenheilkd 1993;203:319-323.
14. Hikichi T, Konno S, Trempe CL. Role of the vitreous in central retinal vein occlusion. Retina 1995;15:29-33.
15. Kado M, Trempe CL. Role of the vitreous in branch retinal vein occlusion. Am J Ophthalmol 1988;105:20-24.
16. Akiba J, Kado M, Kakehashi A, Trempe CL. Role of the vitreous in posterior segment neovascularization in central retinal vein occlusion. Ophthalmic Surg 1991;22:498-502.
17. Fine SL. Vitreous surgery for macular hole in perspective: is there an indication? [editorial] Arch Ophthalmol 1991;109: 635-636.
18. Guyer DR, deBustros S, Diener-West M, Fine SL. Observations on patients with idiopathic macular holes and cysts. Arch Ophthalmol 1992;110:1264-1268.
19. Hikichi T, Akiba J, Trempe CL. Effect of the vitreous on the prognosis of full-thickness idiopathic macular hole. Am J Ophthalmol 1993;116:273-278.
20. Peyman GA, Huamonte FU, Goldberg MF, et al. Four hundred consecutive pars plana vitrectomies with the vitrophage. Arch Ophthalmol 1978;96:45-50.
21. Ghartay KN, Tolentino FI, Freeman HM, et al. Closed vitreous surgery: XVII. Results and complications of pars plana vitrectomy. Arch Ophthalmol 1980;98:1248-1252.
22. Peyman GA, Schulman JA. Intravitreal Surgery: Principles and Practice. Norwalk, CT: Appleton & Lange, 1994:813-850.
23. Park SS, Marcus DM, Duker JS, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102:775-781.
24. Quiroz H, Buzney SM, Furukawa H, et al. Enzymatically induced posterior vitreous detachment [abstract]. Invest Ophthalmol Vis Sci 1984;25(Suppl):307.
25. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849-854.
26. Margherio AR, Margherio RP, Hartzer M, et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology 1998;105:1617-1620.
27. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina 1998;18:7-15.
28. Frenzel EM, Neely KA, Walsh AW, Gregerson DS. New model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998;39:2157-2164.
29. Kang SW, Lee JH, Ham DI, Min WK. Induction of posterior vitreous detachment with dispase in rabbit eyes [abstract]. Invest Ophthalmol Vis Sci 1998;39(Suppl):S379.
30. Harooni M, McMillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina 1998;18:16-22.
31. Alba SA, Kenney MC, Lazarus HS, et al. Intravitreal hyaluronidase and posterior vitreal detachment in the rabbit [abstract]. Invest Ophthalmol Vis Sci 1998;39(Suppl):S829.
32. Hageman GS, Russell SR. Chondroitinase-mediated disinsertion of the primate vitreous body [abstract]. Invest Ophthalmol Vis Sci 1994;35(Suppl):S1260.
33. Thresher RJ, Ehrenberg M, Machemer R. Gas-mediated vitreous compression: an experimental alternative to mechanized vitrectomy. Graefes Arch Clin Exp Ophthalmol 1984;221: 192-198.
34. Miller B, Lean JS, Miller H, Ryan SJ. Intravitreal expanding gas bubble: a morphologic study in the rabbit eye. Arch Ophthalmol 1984;102:1708-1711.
35. Liotta LA, Goldfarb RH, Brundage R, et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981;41(11 pt 1):4629-4636.
36. Henkin J, Marcotte P, Yang H. The plasminogen-plasmin system. Prog Cardiovasc Dis 1992;34:135-164.
37. Sasahara AA, Barker WM, Weaver WD, et al. Clinical studies with the new glycosylated recombinant prourokinase. J Vasc Intervent Radiol 1994;6(6 pt 2 Suppl):84S-93S.
38. Credo BR, Burke SE. Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase. J Vasc Intervent Radiol 1995;6(6 pt 2 Suppl)8S-18S.
39. Foos RY, Wheeler NC. Vitreoretinal juncture: synchysis senilis and posterior vitreous detachment. Ophthalmology 1982; 89:1502-1512.
40. Roth AM, Foos RY. A system for the macroexamination of eyes in the laboratory. Am J Clin Pathol 1973;59:674-683.
41. Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987;28:506-514.
42. Kohno T, Sorgente N, Goodnight R, Ryan SJ. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci 1987;28:515-521.